Skip to main content
Grant Opportunities

Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood and Sleep Technologies with Small Commercial Markets (R44) – Jun 19, 2015

By April 18, 2013No Comments

Funding Opportunity Number: RFA-HL-14-012
Opportunity Category: Discretionary
Funding Instrument Type: Grant
Category of Funding Activity: Health
CFDA Number: 93.233
93.350
93.837
93.838
Eligible Applicants Small businesses
Agency Name: HHS-NIH11
Closing Date: Jun 19, 2015
Award Ceiling:
Expected Number of Awards:
Creation Date: Apr 16, 2013
Funding Opportunity Description: The purpose of the NHLBI SBIR Phase IIB Small Market Award is to provide support to Phase II SBIR awardees developing NHLBI mission-related technologies that address a rare disease or young pediatric populations. The goal of this FOA is to de-risk these technologies so that development can continue with private funding after NHLBI support ends; therefore, applicants must submit a Commercialization Plan, which should include details on any independent third-party funding that has already been secured or is anticipated during the project period. It is expected that the level of this independent third-party funding will be equal to or greater than one-third of the NHLBI funds being requested throughout the project period. Projects proposed in response to this FOA must require eventual Federal regulatory approval/clearance, and may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate, but are not required.

Read more http://www.grants.gov/search/search.do?mode=VIEW&oppId=230693

{iframe}http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-14-012.html{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.